282 related articles for article (PubMed ID: 28507024)
21. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.
Elpek KG; Rubinstein MP; Bellemare-Pelletier A; Goldrath AW; Turley SJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21647-52. PubMed ID: 21098276
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.
Izumi T; Kondo M; Takahashi T; Fujieda N; Kondo A; Tamura N; Murakawa T; Nakajima J; Matsushita H; Kakimi K
Cytotherapy; 2013 Apr; 15(4):481-91. PubMed ID: 23391461
[TBL] [Abstract][Full Text] [Related]
23. The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation.
Wu Z; Xue HH; Bernard J; Zeng R; Issakov D; Bollenbacher-Reilley J; Belyakov IM; Oh S; Berzofsky JA; Leonard WJ
Blood; 2008 Dec; 112(12):4411-9. PubMed ID: 18796634
[TBL] [Abstract][Full Text] [Related]
24. CD122 signaling in CD8+ memory T cells drives costimulation-independent rejection.
Mathews DV; Dong Y; Higginbotham LB; Kim SC; Breeden CP; Stobert EA; Jenkins J; Tso JY; Larsen CP; Adams AB
J Clin Invest; 2018 Oct; 128(10):4557-4572. PubMed ID: 30222140
[TBL] [Abstract][Full Text] [Related]
25. Identification of a potent anti-IL-15 antibody with opposing mechanisms of action in vitro and in vivo.
Finch DK; Midha A; Buchanan CL; Cochrane D; Craggs RI; Cruwys S; Grahames C; Kolbeck R; Lowe DC; Maltby J; Pattison DV; Vousden KA; Ward A; Sleeman MA; Mallinder PR
Br J Pharmacol; 2011 Jan; 162(2):480-90. PubMed ID: 20942844
[TBL] [Abstract][Full Text] [Related]
26. IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.
Tamzalit F; Barbieux I; Plet A; Heim J; Nedellec S; Morisseau S; Jacques Y; Mortier E
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8565-70. PubMed ID: 24912180
[TBL] [Abstract][Full Text] [Related]
27. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
[TBL] [Abstract][Full Text] [Related]
28. Differential outcome of IL-2/anti-IL-2 complex therapy on effector and memory CD8+ T cells following vaccination with an adenoviral vector encoding EBV epitopes.
Smith C; Martinez M; Peet J; Khanna R
J Immunol; 2011 May; 186(10):5784-90. PubMed ID: 21482735
[TBL] [Abstract][Full Text] [Related]
29. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
[TBL] [Abstract][Full Text] [Related]
30. IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses: implications for immune function in aged mice.
Motegi A; Kinoshita M; Inatsu A; Habu Y; Saitoh D; Seki S
J Leukoc Biol; 2008 Oct; 84(4):1047-56. PubMed ID: 18653461
[TBL] [Abstract][Full Text] [Related]
31. IL-15 receptor α signaling constrains the development of IL-17-producing γδ T cells.
Colpitts SL; Puddington L; Lefrançois L
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9692-7. PubMed ID: 26195801
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal homeostasis.
Giron-Michel J; Azzi S; Ferrini S; Chouaib S; Camussi G; Eid P; Azzarone B
Cytokine Growth Factor Rev; 2013 Feb; 24(1):13-22. PubMed ID: 22981349
[TBL] [Abstract][Full Text] [Related]
33. Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.
Peraino JS; Zhang H; Rajasekera PV; Wei M; Madsen JC; Sachs DH; Huang CA; Wang Z
J Immunol Methods; 2014 Mar; 405():57-66. PubMed ID: 24462799
[TBL] [Abstract][Full Text] [Related]
34. Homeostasis of IL-15 dependent lymphocyte subsets in the liver.
Cepero-Donates Y; Rakotoarivelo V; Mayhue M; Ma A; Chen YG; Ramanathan S
Cytokine; 2016 Jun; 82():95-101. PubMed ID: 26778709
[TBL] [Abstract][Full Text] [Related]
35. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
[TBL] [Abstract][Full Text] [Related]
36. Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes.
Pillet AH; Thèze J; Rose T
Hum Immunol; 2011 Nov; 72(11):1013-7. PubMed ID: 21925225
[TBL] [Abstract][Full Text] [Related]
37. Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'.
Levin AM; Bates DL; Ring AM; Krieg C; Lin JT; Su L; Moraga I; Raeber ME; Bowman GR; Novick P; Pande VS; Fathman CG; Boyman O; Garcia KC
Nature; 2012 Mar; 484(7395):529-33. PubMed ID: 22446627
[TBL] [Abstract][Full Text] [Related]
38. IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.
Létourneau S; Krieg C; Pantaleo G; Boyman O
J Allergy Clin Immunol; 2009 Apr; 123(4):758-62. PubMed ID: 19348914
[TBL] [Abstract][Full Text] [Related]
39. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH
Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198
[TBL] [Abstract][Full Text] [Related]
40. IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy.
Su EW; Moore CJ; Suriano S; Johnson CB; Songalia N; Patterson A; Neitzke DJ; Andrijauskaite K; Garrett-Mayer E; Mehrotra S; Paulos CM; Doedens AL; Goldrath AW; Li Z; Cole DJ; Rubinstein MP
Sci Transl Med; 2015 Oct; 7(311):311ra170. PubMed ID: 26511507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
